A citation-based method for searching scientific literature

Frank H Yu, Massimo Mantegazza, Ruth E Westenbroek, Carol A Robbins, Franck Kalume, Kimberly A Burton, William J Spain, G Stanley McKnight, Todd Scheuer, William A Catterall. Nat Neurosci 2006
Times Cited: 648



C Depienne, O Trouillard, C Saint-Martin, I Gourfinkel-An, D Bouteiller, W Carpentier, B Keren, B Abert, A Gautier, S Baulac, A Arzimanoglou, C Cazeneuve, R Nabbout, E LeGuern. J Med Genet 2009
Times Cited: 226




List of shared articles



Times cited

New avenues in molecular genetics for the diagnosis and application of therapeutics to the epilepsies.
Pedro H M Magalhães, Helena T Moraes, Maria C P Athie, Rodrigo Secolin, Iscia Lopes-Cendes. Epilepsy Behav 2021
1

Sodium channelopathies in neurodevelopmental disorders.
Miriam H Meisler, Sophie F Hill, Wenxi Yu. Nat Rev Neurosci 2021
6

Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program.
Chelsea D Pernici, Jeffrey A Mensah, E Jill Dahle, Kristina J Johnson, Laura Handy, Lauren Buxton, Misty D Smith, Peter J West, Cameron S Metcalf, Karen S Wilcox. Epilepsia 2021
1

SCN1A-related epilepsy with recessive inheritance: Two further families.
Raffaella Moretti, Lionel Arnaud, Delphine Bouteiller, Oriane Trouillard, Patricia Moreau, Julien Buratti, Agnès Rastetter, Boris Keren, Vincent Des Portes, Joseph Toulouse,[...]. Eur J Paediatr Neurol 2021
0

Dravet Syndrome: Novel Approaches for the Most Common Genetic Epilepsy.
Lori L Isom, Kelly G Knupp. Neurotherapeutics 2021
1

Dravet Variant SCN1A A1783V Impairs Interneuron Firing Predominantly by Altered Channel Activation.
Nikolas Layer, Lukas Sonnenberg, Emilio Pardo González, Jan Benda, Ulrike B S Hedrich, Holger Lerche, Henner Koch, Thomas V Wuttke. Front Cell Neurosci 2021
0

Mutation spectrum of the SCN1A gene in a Hungarian population with epilepsy.
Ágnes Till, Judith Zima, Anett Fekete, Judit Bene, Márta Czakó, András Szabó, Béla Melegh, Kinga Hadzsiev. Seizure 2020
1

A selective NaV1.1 activator with potential for treatment of Dravet syndrome epilepsy.
Chun Yuen Chow, Yanni K Y Chin, Linlin Ma, Eivind A B Undheim, Volker Herzig, Glenn F King. Biochem Pharmacol 2020
6